Osteotropism of Breast and Prostate Cancer: Clinical and Experimental Perspective
Journal Title: International Journal of Immunotherapy and Cancer Research - Year 2017, Vol 3, Issue 2
Abstract
Breast and prostate cancer are the two most common invasive cancers in women and men, respectively. Although these cancers arise in organs that are different in terms of structure and function, both organs require sexual hormones for their development, and tumors that arise from them are typically hormone-dependent and have extraordinary affinity each other [1]. That breast and prostate cancer share several biological, genetic and epidemiological aspects is known since 1950s. Pioneering studies designed to ascertain the genetic bases of breast cancer detected a higher frequency of prostate cancer among the relatives of women with breast cancer, which led them to propose that prostate cancer could be the male equivalent of at least some female mammary carcinomas [2].
Authors and Affiliations
Scimeca Manuel, Starace Francesca, Gratti Deborah, Sapia Viviana Benedicta, Bonfiglio Rita, Bonanno Elena
Keywords
Related Articles
- EP ID EP348825
- DOI 10.17352/2455-8591.000016
- Views 99
- Downloads 0
Immunomodulatory Effects of Food Additives
Food items that are unprocessed and do not contain preservatives, artificial colours, chemicals, fillers, artificial flavours etc are called as Natural foods. Natural foods are the best source of nutrition and health. Su...
Anti-VEGF Therapy Induces Proteinuria through Endothelial Disorganization Leading to Nephrin Decrease in Podocytes
Background: VEGF is involved in cancer development by stimulating neo-angiogenesis and tumor proliferation. Anti-angiogenic therapies, especially tyrosine kinase inhibitors such as sunitinib, have significantly improved...
Are Cladribine and Rituximab Enough for the Treatment of Relapsed Hairy Cell Leukemia?
Introduction: Hairy cell leukemia is a rare B-cell lymph proliferation with long-term survivals, in general. Although therapeutic possibilities have progressed over time, many patients have recurrences and the disease ca...
Analysis of Risk Factors for Development of Hepatocellular Carcinoma in Chronic HBV - Infected Liver Cirrhosis Patients: A Meta-Analysis
The 5-year cumulative incidence rate of hepatocellular carcinoma (HCC) in chronic HBV -infected liver cirrhosis (LC) patients was up to 5%-30%. However, existing medical interventions can’t cure chronic HBV -infected LC...
Immunosuppressive and Cytotoxic Potential of Flavonoids from Medicinal Plants: Preliminary Investigation for Anticancer Activity
Introduction: Attention related to scientific and research interest towards naturally derived compounds from medicinal plant products as they are considered to have less toxic side effects as compared to current treatmen...